Pricing Log in Create free account

ABVC BioPharma, Inc. (ABVC) vs Estrella Immunopharma, Inc. (ESLA)

ABVC BioPharma, Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and Estrella Immunopharma, Inc. are of similar size ($24.9M and $23.3M). Across the 8 metrics below, ABVC BioPharma, Inc. leads on 4 and Estrella Immunopharma, Inc. on 4.

Valuation

Metric ABVC ESLA Biotechnology median
P/E n/m n/m 8.50
P/S 18.38 n/m 9.71
P/B 1.95 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 19.64 n/m 9.21
Earnings yield (36.91%) (56.72%) (33.15%)
Free cash flow yield (11.33%) (50.75%) (25.50%)

Profitability

Metric ABVC ESLA Biotechnology median
Gross margin 99.97% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) 148.05% (56.36%)
Return on assets (39.88%) (416.74%) (48.04%)
Return on invested capital (33.45%) 0.00% 0.00%

Growth

Metric ABVC ESLA Biotechnology median
Revenue growth (TTM) 5,035.43% — 6.02%
EPS growth (last fiscal year) 7.14% (188.78%) 30.26%
Revenue growth, 5-year CAGR (6.20%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 0.20 4.72
Net debt to EBITDA 0.21 0.11 0.96

Dividend

Metric ABVC ESLA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABVC ESLA Biotechnology median
Market cap 24.89m 23.28m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack